在单细胞分辨率下,揭开细胞类型对帕金森病的特异反应
Araks Martirosyan1, Rizwan Ansari2, Francisco Pestana1
1VIB Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.
Molecular neurodegeneration
|January 20, 2024
概括
帕金森病涉及神经元损失和质细胞增加. 这项研究揭示了与多巴胺相关的细胞亚群的枯竭,并确定了参与神经退行的主要基因.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,其特点是黑色物质紧部分 (SNpc) 中的多巴胺基神经元损失.
- 在不同细胞类型中驱动PD病理的分子机制仍然不太清楚.
研究的目的:
- 从PD病例和对照中对人类死后SNPc进行单核转录组分析.
- 描述细胞类型特定的转录组变化,并确定PD中的新型亚群.
主要方法:
- 从15个PD病例和14个对照组 (∼84K个核) 中对人类死后SNPc进行单核RNA测序.
- 分析所有主要的大脑细胞类型及其子群.
- 耗尽亚种群的标记基因分析.
主要成果:
- 在PD样本中,神经元细胞显著减少,质细胞和T细胞增加.
- 在PD中,氨酸氧酶 (TH) 丰富的星体细胞,微质细胞,寡细胞和神经元的耗尽.
- 在枯竭的亚种群中识别了28个重叠基因,包括与多巴胺代谢相关的基因 (例如,ALDH1A1,SLC6A3,SLC18A2).
结论:
- 这项研究为了解PD提供了有价值的转录学资源.
- 突出了新的细胞亚群和细胞类型特定的基因组的存在,这些基因组参与了多巴胺基神经元退化和帕金森病中的质反应.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
7.2K
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
